BROOKFIELD Corp ON Has $14.06 Million Stock Position in Ventas, Inc. $VTR

BROOKFIELD Corp ON reduced its position in shares of Ventas, Inc. (NYSE:VTRFree Report) by 38.2% in the 1st quarter, HoldingsChannel reports. The firm owned 171,919 shares of the real estate investment trust’s stock after selling 106,208 shares during the period. BROOKFIELD Corp ON’s holdings in Ventas were worth $14,060,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in VTR. NewEdge Advisors LLC boosted its holdings in shares of Ventas by 856.1% in the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after acquiring an additional 7,097 shares in the last quarter. Empowered Funds LLC increased its holdings in Ventas by 6.8% during the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after purchasing an additional 536 shares in the last quarter. Woodline Partners LP increased its holdings in Ventas by 46.8% during the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after purchasing an additional 11,739 shares in the last quarter. Focus Partners Wealth raised its position in Ventas by 130.4% in the 1st quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after purchasing an additional 12,233 shares during the last quarter. Finally, Gamco Investors INC. ET AL bought a new position in Ventas in the 2nd quarter valued at $805,000. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Ventas Trading Up 0.1%

Shares of VTR opened at $100.61 on Monday. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95. Ventas, Inc. has a 12-month low of $65.15 and a 12-month high of $100.84. The firm has a market capitalization of $48.92 billion, a PE ratio of 182.94, a price-to-earnings-growth ratio of 2.16 and a beta of 0.70. The stock’s fifty day simple moving average is $88.17 and its 200-day simple moving average is $84.91.

Ventas (NYSE:VTRGet Free Report) last posted its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. Ventas’s revenue was up 22.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.84 EPS. As a group, research analysts predict that Ventas, Inc. will post 3.88 earnings per share for the current year.

Ventas Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th were given a dividend of $0.52 per share. The ex-dividend date was Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a yield of 2.1%. Ventas’s dividend payout ratio is presently 378.18%.

Insider Activity

In other news, Director Walter C. Rakowich sold 1,152 shares of the firm’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the transaction, the director owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. This trade represents a 3.90% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler purchased 2,500 shares of the stock in a transaction dated Wednesday, June 3rd. The shares were acquired at an average price of $78.81 per share, with a total value of $197,025.00. Following the transaction, the director owned 19,202 shares in the company, valued at $1,513,309.62. This trade represents a 14.97% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.53% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

VTR has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. boosted their price objective on Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Monday, May 11th. Weiss Ratings raised Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a report on Tuesday, July 21st. Evercore reiterated an “outperform” rating and set a $95.00 price target on shares of Ventas in a research report on Wednesday, April 29th. Mizuho upped their price target on shares of Ventas from $98.00 to $104.00 and gave the stock an “outperform” rating in a research report on Wednesday. Finally, KeyCorp increased their price objective on shares of Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Fifteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $96.50.

Check Out Our Latest Analysis on VTR

Ventas Profile

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

See Also

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTRFree Report).

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.